[HTML][HTML] Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations
J Ngeow, K Stanuch, JL Mester… - Journal of Clinical …, 2014 - ncbi.nlm.nih.gov
J Ngeow, K Stanuch, JL Mester, JS Barnholtz-Sloan, C Eng
Journal of Clinical Oncology, 2014•ncbi.nlm.nih.govSecond Malignant Neoplasms in Patients With Cowden Syndrome With Underlying Germline
PTEN Mutations - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC4039869 Other
Formats PubReader PDF (133K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
PTEN Mutations - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC4039869 Other
Formats PubReader PDF (133K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
Abstract
Purpose
Patients with Cowden syndrome (CS) with underlying germline PTEN mutations are at increased risk of breast, thyroid, endometrial, and renal cancers. To our knowledge, risk of subsequent cancers in these patients has not been previously explored or quantified.
ncbi.nlm.nih.gov